Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?

Venkata Yalamanchili, Robert F. Reilly

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	387-388
Number of pages	2
Journal	Seminars in Dialysis
Volume	24
Issue number	4
DOIs	https://doi.org/10.1111/j.1525-139X.2011.00885.x
State	Published - Jul 2011

ASJC Scopus subject areas

Nephrology

Access to Document

10.1111/j.1525-139X.2011.00885.x

Other files and links

Link to publication in Scopus

Cite this

@article{7a38342b6dcf454dad08406a676a12f3,

title = "Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?",

author = "Venkata Yalamanchili and Reilly, {Robert F.}",

note = "Copyright: Copyright 2012 Elsevier B.V., All rights reserved.",

year = "2011",

month = jul,

doi = "10.1111/j.1525-139X.2011.00885.x",

language = "English (US)",

volume = "24",

pages = "387--388",

journal = "Seminars in Dialysis",

issn = "0894-0959",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?

AU - Yalamanchili, Venkata

AU - Reilly, Robert F.

N1 - Copyright: Copyright 2012 Elsevier B.V., All rights reserved.

PY - 2011/7

Y1 - 2011/7

UR - http://www.scopus.com/inward/record.url?scp=80051815001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051815001&partnerID=8YFLogxK

U2 - 10.1111/j.1525-139X.2011.00885.x

DO - 10.1111/j.1525-139X.2011.00885.x

M3 - Comment/debate

C2 - 21851395

AN - SCOPUS:80051815001

SN - 0894-0959

VL - 24

SP - 387

EP - 388

JO - Seminars in Dialysis

JF - Seminars in Dialysis

IS - 4

ER -